In BS fibroblasts, HeLa cells and breast cancer cell lines and tissues, low levels or absence of CDA were associated with higher levels of Tau mRNA and protein, consistent with a physiological mechanism regulating the levels of both proteins. This evidence concerns the gene CDA and breast carcinoma.